# The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry

> **NCT03479437** · — · COMPLETED · sponsor: **Rhythm Pharmaceuticals, Inc.** · enrollment: 303 (actual)

## Conditions studied

- Genetic Forms of Extreme Obesity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03479437
- **Lead sponsor:** Rhythm Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-15
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2021-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03479437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03479437, "The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03479437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*